| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2702a0981f41c0c0a141f781bd036416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2014-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e8ed79e905c8d3e1e13b1514e89b095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afff0c9439fe167b9d18cdaec8240f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_360bd4df77bd69f644b795e1d6cd239f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5173be1b8aee38adbdee8a642e316530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72fe0c4dedee44a2e53ab0729ac7504c |
| publicationDate |
2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160055934-A |
| titleOfInvention |
Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions |
| abstract |
Aspects of the invention include a method of treating withdrawal syndrome by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver a non-standard dose of dexmedetomidine to a subject diagnosed with withdrawal syndrome . In practicing the method according to certain embodiments, the transdermal delivery device having a dexmedetomidine composition is applied to a subject and is administered to a subject in a manner sufficient to deliver a non-dose-adjusted amount of dexmedetomidine for treating withdrawal syndrome in the subject As shown in FIG. A kit comprising a transdermal delivery device configured to deliver a non-dose amount of dexmedetomidine sufficient to perform the method, and a transdermal delivery device is also provided. |
| priorityDate |
2013-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |